GL CHEMTEC

GL CHEMTEC is an independent North American CDMO offering integrated solutions in small‑molecule API development, biomedical polymers, and GMP contract manufacturing.

Founded in 2002 and headquartered in Oakville, Ontario, GL CHEMTEC is a founder‑led life‑sciences partner combining expertise in small‑molecule chemistry and tailored polymer design. With more than two decades of experience, the company specialises in advancing drug discovery, drug delivery systems, and biomedical materials from early research through to clinical-stage manufacturing. GL CHEMTEC’s North American facilities support clients with scalable chemistry services, pioneering green‑chemistry practices and comprehensive quality systems certified to ISO 9001:2015 and ISO 13485:2016.

Key Products & Services
Small‑molecule API development

– Synthetic route creation, process optimisation and R&D at milligram to multi‑kilogram scale in ISO‑certified labs.

Tailored biomedical polymers & drug‑delivery systems

– Custom polymers, hydrogels, films, emulsions and ophthalmic materials (e.g. contact lenses) to enhance solubility, bioavailability and delivery.

Integrated chemistry solutions

– Combination of small‑molecule chemistry and polymer science to deliver cohesive R&D through to manufacturing services.

Scale‑up and GMP contract manufacturing

– Equipped with R&D, Kilo, pilot and Class 6 cleanroom facilities, plus analytical laboratories for full process and production oversight.

Analytical and quality assurance

– In‑house analytical services including HPLC, GC, LC‑MS, NMR and thermal analysis; full documentation to support regulatory submissions.

With a strong North American footprint and a commitment to sustainable practices and scientific excellence, GL CHEMTEC provides secure, flexible pathways for drug development—from early discovery through to clinic-ready supply. Its customer‑centric culture, combined with advanced facility infrastructure and regulatory-grade quality, positions it as a trusted partner for pharmaceutical and life-science innovators seeking to progress complex molecules and advanced delivery systems.